| David C Avallon, | |
|
1 Atlantic St Ste 201, Stamford, CT 06901-2438 | |
| (203) 355-2225 | |
| (203) 355-2235 |
| Full Name | David C Avallon |
|---|---|
| Gender | Male |
| Speciality | Chiropractor |
| Location | 1 Atlantic St Ste 201, Stamford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033633722 | NPI | - | NPPES |
| 2079 | Other | CT | CONNECTICUT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 2079 (Connecticut) | Primary |
| Provider Name | Avallon Chiropractic & Wellness, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1811616725 PECOS PAC ID: 8224404595 Enrollment ID: O20221012001812 |
News Archive
A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows.
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that key data covering the scientific and clinical development of its lead cancer vaccine, IMA901, have been published in Nature Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David C Avallon, 1220 Post Road, Suite 1, Fairfield, CT 06824 Ph: (203) 955-1147 | David C Avallon, 1 Atlantic St Ste 201, Stamford, CT 06901-2438 Ph: (203) 355-2225 |
News Archive
A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows.
Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC).
Mast Therapeutics, Inc. today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today announced that key data covering the scientific and clinical development of its lead cancer vaccine, IMA901, have been published in Nature Medicine.
› Verified 3 days ago
Strawberry Hill Chiropractic Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: One Strawberry Hill Court, Ste L4, Stamford, CT 06902 Phone: 203-325-2990 Fax: 203-353-9572 | |
Dr. Elissa Diamond, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1250 Summer St, Suite 202, Stamford, CT 06905 Phone: 203-327-3222 Fax: 203-978-9079 | |
Mr. Mel Gabriel, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 19 3rd St, Stamford, CT 06905 Phone: 203-325-1533 Fax: 203-327-9656 | |
Dr. Ian Wyatt Keyser, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 970 Summer St Fl 1, Stamford, CT 06905 Phone: 203-276-1293 | |
Dr. Michael Anthony Naccarella, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1867 Summer St, Stamford, CT 06905 Phone: 203-975-7000 Fax: 203-975-0876 | |
Stamford Healthcare Associates, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1425 Bedford St. Unit 1g, Stamford, CT 06905 Phone: 203-569-0067 Fax: 203-504-2951 |